XML 126 R85.htm IDEA: XBRL DOCUMENT v3.25.2
Share-Based Compensation - Stock Options and Share Appreciation Rights ("SARs") (Details) - Share-based Payment Arrangement, Options and Stock Appreciation Rights (SARS)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Mar. 31, 2025
USD ($)
$ / shares
shares
Number of Shares  
Outstanding at March 31, 2024 (in shares) 1.3
Granted (in shares) 0.0
Exercised (in shares) 0.0
Forfeited or expired (in shares) (0.1)
Outstanding at March 31, 2025 (in shares) 1.2
Vested or expected to vest (in shares) 1.2
Exercisable (in shares) 1.2
Weighted-Average Exercise Price  
Outstanding at March 31, 2024, Weighted-Average Exercise Price (in usd per share) | $ / shares $ 11.14
Granted, Weighted-Average Exercise Price (in usd per share) | $ / shares 0
Exercised, Weighted-Average Exercise Price (in usd per share) | $ / shares 6.49
Forfeited or expired, Weighted-Average Exercise Price (in usd per share) | $ / shares 15.81
Outstanding at March 31, 2025, Weighted-Average Exercise Price (in usd per share) | $ / shares 11.08
Vested or expected to vest, Weighted-Average Exercise Price (in usd per share) | $ / shares 11.08
Exercisable, Weighted-Average Exercise Price (in usd per share) | $ / shares $ 11.08
Stock Options Additional Disclosures  
Outstanding, Weighted-Average Remaining Contractual Term (in years) 3 years 8 months 26 days
Outstanding, Aggregate Intrinsic Value | $ $ 0.1
Vested or expected to vest, Weighted-Average Remaining Contractual Term (in years) 3 years 8 months 26 days
Vested or expected to vest, Aggregate Intrinsic Value | $ $ 0.1
Exercisable, Weighted-Average Remaining Contractual Term (in years) 3 years 8 months 26 days
Exercisable, Aggregate Intrinsic Value | $ $ 0.1
Maximum  
Number of Shares  
Exercised (in shares) 0.1